Abstract:Introduction Dendritic cells (DC) are crucial for initiating and shaping immune responses. So far, little is known about the functional specialization of human DC subsets in (local) inflammatory conditions. We profiled conventional (c)DC1, cDC2 and monocytes based on phenotype, transcriptome and function from a local inflammatory site, namely synovial fluid (SF) from patients suffering from a chronic inflammatory condition, Juvenile Idiopathic Arthritis (JIA) as well as patients with rheumatoid arthritis (RA). Methods Paired PB and SF samples from 32 JIA and 4 RA patients were collected for mononuclear cell isolation. Flow cytometry was done for definition of antigen presenting cell (APC) subsets. Cell sorting was done on the FACSAria II or III. RNA sequencing was done on SF APC subsets. Proliferation assays were done on co-cultures after CD3 magnetic activated cell sorting (MACS). APC Toll-like receptor (TLR) stimulation was done using Pam3CSK4, Poly(I:C), LPS, CpG-A and R848. Cytokine production was measured by Luminex. Results cDC1, a relatively small DC subset in blood, are strongly enriched in SF, and showed a quiescent immune signature without a clear inflammatory profile, low expression of pathogen recognition receptors (PRRs), chemokine and cytokine receptors, and poor induction of T cell proliferation and cytokine production, but selective production of IFNλ upon polyinosinic:polycytidylic acid exposure. In stark contrast, cDC2 and monocytes from the same environment, showed a pro-inflammatory transcriptional profile, high levels of (spontaneous) pro-inflammatory cytokine production, and strong induction of T cell proliferation and cytokine production, including IL-17. Although the cDC2 and monocytes showed an overlapping transcriptional core profile, there were clear differences in the transcriptional landscape and functional features, indicating that these cell types retain their lineage identity in chronic inflammatory conditions. Discussion Our findings suggest that at the site of inflammation, there is specific functional programming of human DCs, especially cDC2. In contrast, the enriched cDC1 remain relatively quiescent and seemingly unchanged under inflammatory conditions, pointing to a potentially more regulatory role.

The lifespan and kinetics of human dendritic cell subsets and their precursors in health and inflammation

Human dendritic cell subsets: an update

Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line

Transcriptional control of dendritic cell development and functions

The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting.

Mapping the human DC lineage through the integration of high-dimensional techniques

Novel Insights into the Relationships Between Dendritic Cell Subsets in Human and Mouse Revealed by Genome-Wide Expression Profiling

Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity

Transcriptional Basis of Mouse and Human Dendritic Cell Heterogeneity

Regulation of the lifespan in dendritic cell subsets.

Development of Dendritic Cell System.

Single-cell Analyses Reveal Functional Classification of Dendritic Cells and Their Potential Roles in Inflammatory Disease.

Chromatin Landscape Underpinning Human Dendritic Cell Heterogeneity

The Development, Maturation, and Turnover Rate of Mouse Spleen Dendritic Cell Populations

Human dendritic cell subsets and function in health and disease

Human dendritic cells in cancer

Human Dendritic Cell Subsets from Spleen and Blood Are Similar in Phenotype and Function but Modified by Donor Health Status.

Conventional dendritic cells type 1 are strongly enriched, quiescent and relatively tolerogenic in local inflammatory arthritis

Intrasplenic Steady-State Dendritic Cell Precursors That Are Distinct from Monocytes

Dendritic Cells: Origin and Differentiation

The Equivalents of Human Blood and Spleen Dendritic Cell Subtypes Can Be Generated in Vitro from Human CD34 + Stem Cells in the Presence of Fms -Like Tyrosine Kinase 3 Ligand and Thrombopoietin